# US 2005/0089581 A1 · Magnesium-containing compositions and methods for enhancing dehydroepiandrosterone levels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0089581 A1
- Document ID: US20050089581A1
- Status: Published application
- Kind: A1
- Application number: 10/690,927
- Filed: 2003-10-22
- Published: 2005-04-28
- Earliest claimed: 2003-10-22
- Inventors: C. Shealy
- Web page: https://patentgrep.com/patent/US20050089581A1

## CPC

- A61K 33/14: Alkali metal chlorides; Alkaline earth metal chlorides
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/38: Cellulose; Derivatives thereof
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Compositions and methods for using the same to restore dehydroepiandrosterone (DHEA) levels in humans are described. The compositions comprise magnesium chloride, a suitable solvent, a gelling agent and a glycerin. The compositions are administered to the skin of humans to enhance DHEA levels through the transdermal absorption of magnesium. The compositions can be administered in various forms, including as a lotion, an ointment, or as a bath additive.

## Claims

### Claim 1

A method of raising serum DHEA levels in an individual, the method comprising applying a therapeutically effective amount of a magnesium-containing composition to the individual's skin, the magnesium-containing composition comprising about 25 to 35 weight percent magnesium chloride, a solvent, a gelling agent and glycerin.

### Claim 2 (depends on 1)

The method of claim 1 wherein the magnesium-containing composition is substantially free of sodium ions.

### Claim 3 (depends on 1)

The method of claim 1 wherein the magnesium-containing composition is substantially free of sulfate ions.

### Claim 4 (depends on 1)

The method of claim 1 wherein the gelling agent is a cellulose.

### Claim 5 (depends on 4)

The method of claim 4 wherein the cellulose is methyl cellulose.

### Claim 6 (depends on 1)

The method of claim 1 wherein the solvent is water.

### Claim 7 (depends on 1)

The method of claim 1 wherein the magnesium-containing composition comprises about 60 to 75 weight percent solvent.

### Claim 8 (depends on 1)

The method of claim 1 wherein the magnesium-containing composition comprises about 0.1 to 5 weight percent gelling agent.

### Claim 9 (depends on 1)

The method of claim 1 wherein the magnesium-containing composition comprises about 0.1 to 5 weight percent glycerin.

### Claim 10 (depends on 1)

The method of claim 1 wherein the magnesium-containing composition further comprises one or more additives selected from the group consisting of soaps, perfumes and dyes.

### Claim 11

A method of raising serum DHEA levels in an individual, the method comprising applying a therapeutically effective amount of a magnesium-containing composition to the individual's skin, the magnesium-containing composition comprising about 25 to 35 weight percent magnesium chloride, about 60 to 75 weight percent water, about 0.1 to 5 weight percent methyl cellulose and about 0.1 to 5 weight percent glycerin.

### Claim 12 (depends on 11)

The method of claim 11 wherein the magnesium-containing composition is substantially free of sodium ions.

### Claim 13 (depends on 11)

The method of claim 11 wherein the magnesium-containing composition is substantially free of sulfate ions.

### Claim 14

A composition for the transdermal absorption of magnesium comprising:
(a) about 25 to 35 weight percent magnesium chloride;
(b) about 60 to 75 weight percent water;
(c) about 0.1 to 5 weight percent of a gelling agent; and
(d) about 0.1 to 5 weight percent glycerin.

### Claim 15 (depends on 14)

The composition of claim 14, wherein the gelling agent is a cellulose.

### Claim 16 (depends on 14)

The composition of claim 14 wherein the composition is substantially free of sodium ions.

### Claim 17 (depends on 14)

The composition of claim 14 wherein the composition is substantially free of sulfate ions.
